Published online 27 October 2004
Nucleic Acids Research, Vol. 32 No. 19 © Oxford University Press 2004; all rights reserved
Multiple defects in translation associated with altered ribosomal protein L4
School of Biological Sciences, University of Missouri-Kansas City, 5007 Rockhill Road, Kansas City, MO 64110, USA and 1 J. W. Wilson Laboratory, Department of Molecular and Cellular Biology and Biochemistry, Brown University, Providence, RI 02912, USA
* To whom correspondence should be addressed. Tel: +1 816 235 6372; Fax: +1 816 235 5595; Email: oconnormi{at}umkc.edu
Received September 7, 2004; Revised and Accepted October 8, 2004
The ribosomal proteins L4 and L22 form part of the peptide exit tunnel in the large ribosomal subunit. In Escherichia coli, alterations in either of these proteins can confer resistance to the macrolide antibiotic, erythromycin. The structures of the 30S as well as the 50S subunits from each antibiotic resistant mutant differ from wild type in distinct ways and L4 mutant ribosomes have decreased peptide bond-forming activity. Our analyses of the decoding properties of both mutants show that ribosomes carrying the altered L4 protein support increased levels of frameshifting, missense decoding and readthrough of stop codons during the elongation phase of protein synthesis and stimulate utilization of non-AUG codons and mutant initiator tRNAs at initiation. L4 mutant ribosomes are also altered in their interactions with a range of 30S-targeted antibiotics. In contrast, the L22 mutant is relatively unaffected in both decoding activities and antibiotic interactions. These results suggest that mutations in the large subunit protein L4 not only alter the structure of the 50S subunit, but upon subunit association, also affect the structure and function of the 30S subunit.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. G. Lawrence, L. Lindahl, and J. M. Zengel Effects on Translation Pausing of Alterations in Protein and RNA Components of the Ribosome Exit Tunnel J. Bacteriol., September 1, 2008; 190(17): 5862 - 5869. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Binet and A. T. Maurelli Frequency of Development and Associated Physiological Cost of Azithromycin Resistance in Chlamydia psittaci 6BC and C. trachomatis L2 Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4267 - 4275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Liiv and M. O'Connor Mutations in the Intersubunit Bridge Regions of 23 S rRNA J. Biol. Chem., October 6, 2006; 281(40): 29850 - 29862. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Meskauskas, A. N. Petrov, and J. D. Dinman Identification of Functionally Important Amino Acids of Ribosomal Protein L3 by Saturation Mutagenesis Mol. Cell. Biol., December 15, 2005; 25(24): 10863 - 10874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. TSAGKALIA, F. LEONTIADOU, M. A. XAPLANTERI, G. PAPADOPOULOS, D. L. KALPAXIS, and T. CHOLI-PAPADOPOULOU Ribosomes containing mutants of L4 ribosomal protein from Thermus thermophilus display multiple defects in ribosomal functions and sensitivity against erythromycin RNA, November 1, 2005; 11(11): 1633 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bogdanovich, L. M. Ednie, S. Shapiro, and P. C. Appelbaum Antistaphylococcal Activity of Ceftobiprole, a New Broad-Spectrum Cephalosporin Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4210 - 4219. [Abstract] [Full Text] [PDF] |
||||




